BioLineRx (BLRX) Reports In-Line Q2 EPS

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of $0.00. Revenue for the quarter came in at $5.39 million.

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Activist investors push Seer, Inc. to disclose go-private timeline
• Popular stocks with increasing option volume: SPCX MU SMCI INTC AMZN NFLX HTZ MSTR NBIS PLTR SNDK CRWV ORCL CSCO
• Apple opens Advanced Manufacturing Center in Houston for SMBs